Objectif
An ideal intervention in a chronic inflammatory disease such as Rheumatoid Arthritis (RA) would be a preventive one. In order to develop preventive strategies and therapies two key developments need to occur: (1) Biomarkers need to be identified that can be used to predict an individual’s risk of developing RA. (2) Modifiable disease mechanisms need to be identified and characterized in the early phases of disease. The key objective of the TEAM consortium is to specifically identify diagnostic biomarkers and disease mechanisms operating during the transition from health to rheumatoid arthritis. Our consortium will achieve this by developing a collaborative, integrated programme of work that links researchers with key SMEs involved in biomarker development to produce a “personalized predictive bioprofile” for patients destined to develop RA. The Euro-TEAM consortium will deliver a step change in the development of biomarkers and diagnostic kits that are timely, strategically important for European SMEs, and based on a disease (RA) in which concrete genetic and environmental risk factors have already been established. Firstly, it will directly compare biomarkers in the preclinical phases of disease with established markers in the clinical phases. Secondly, it will look beyond the synovium interrogating lymphoid, lung and periodontal tissue in a first-in-class approach to measuring systemic changes in the earliest phases of disease. Thirdly, it will place great emphasis on understanding why synovial inflammation resolves in some individuals and develop biomarkers of this “reverse” phase. Fourthly, it will explore a key cell type (stromal cells) that has been almost completely ignored in current biomarker studies. Finally, it will directly involve patients and other specialists, particularly from the fields of genetics, ethics and patient and public involvement in helping to visualize and communicate risk following a positive biomarker test.
Champ scientifique
Appel à propositions
FP7-HEALTH-2012-INNOVATION-1
Voir d’autres projets de cet appel
Régime de financement
CP-FP - Small or medium-scale focused research projectCoordinateur
B15 2TT Birmingham
Royaume-Uni
Voir sur la carte
Participants (15)
8006 ZURICH
Voir sur la carte
2333 ZA Leiden
Voir sur la carte
17177 Stockholm
Voir sur la carte
1105AZ Amsterdam
Voir sur la carte
1090 Wien
Voir sur la carte
LS2 9JT Leeds
Voir sur la carte
10117 Berlin
Voir sur la carte
G12 8QQ Glasgow
Voir sur la carte
91054 Erlangen
Voir sur la carte
M13 9PL Manchester
Voir sur la carte
100 44 Stockholm
Voir sur la carte
Participation terminée
1105 BA Amsterdam
Voir sur la carte
55129 MAINZ
Voir sur la carte
101 Reykjavik
Voir sur la carte
751 05 Uppsala
Voir sur la carte